Skip to content
A9020Assembly2023-2024 SessionSame asS8097

Create Blood Clot Policy Group

Official title

“Establishes a blood clot and pulmonary embolism policy workgroup”

Sponsor Michaelle C. SolagesAD-22Affects Health
Status
In Assembly Committee
Health
Impact
4/10
Low
Passage
0%

Bill progress

Step 2 of 7

In committee · Health

What's happening

This bill creates a workgroup to study and recommend policies on blood clots and pulmonary embolism prevention and treatment in New York.

Why it matters

  1. Addresses a significant but often underrecognized health threat. Blood clots and pulmonary embolisms cause serious complications and deaths, yet data collection and awareness are inconsistent. The workgroup could spur improvements in tracking, prevention, and treatment that directly impact patient safety.

  2. Brings together diverse perspectives. By mandating participation from clinicians, survivors, families, and advocates, the workgroup is positioned to identify gaps in care and patient communication that might not be visible to policymakers or health professionals alone.

  3. Potential to reshape standards and patient education. The workgroup’s tasks explicitly include recommending new standards of care, risk surveillance, and patient/family notification policies, which could lead to more proactive risk identification and better-informed patients in hospitals and other care settings.

  4. Creates a blueprint for data-driven policy change. By requiring a comprehensive report and public transparency via the health department’s website, the bill aims to ensure that findings and recommendations inform both lawmakers and the public, potentially laying groundwork for future legislative or regulatory action.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

  • New York State Department of Health

    The commissioner would establish the workgroup, appoint its chair and publish its recommendations on the department’s website.

  • Blood clot survivors, bereaved families and patient advocates

    They would be represented on a workgroup studying blood clot impacts and recommending improvements to patient awareness and risk notices.

  • Health care providers

    The workgroup would develop a risk surveillance system to help them identify patients at higher risk of blood clots and pulmonary embolisms.

  • Hospitals, nursing homes and other licensed health care facilities

    The workgroup would recommend policies to improve surveillance and detection of patients at higher risk of blood clots in these settings.

Headline styles

Create Blood Clot Policy Group

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Michaelle C. Solages

Assembly Member · Assembly District 22

Chair, Local Governments

No co-sponsors yet.

History

  1. Print number 9020a
  2. Amend and recommit to health
  3. Referred to health

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

S8097Senate

Study Blood Clot Risks

In Assembly Committee · Health · Sponsor Roxanne J. Persaud

Impact 4 · Low0% to pass

Full text

2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

9020--A

IN ASSEMBLY

February 5, 2024

Introduced by M. of A. SOLAGES -- read once and referred to the Committee on Health -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee

AN ACT to amend the public health law, in relation to establishing a blood clot and pulmonary embolism policy workgroup; and providing for the repeal of such provisions upon expiration thereof

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Section 206 of the public health law is amended by adding a new subdivision 32 to read as follows:

32. (a) The commissioner shall establish a blood clot and pulmonary embolism policy workgroup. The workgroup shall be composed of health care providers, patients who have experienced blood clots, family members of patients who have died from blood clots, advocates, and other interested parties and associations. The governor, the temporary president of the senate and the speaker of the assembly shall each appoint two members to the workgroup. The commissioner shall appoint the chair of the workgroup.

(b) Members of the workgroup shall receive no compensation for their services, but may be paid their actual and necessary expenses incurred in serving the workgroup.

(c) It shall be the duty of the workgroup to study and issue recommendations pertaining to the incidence and treatment of blood clots and pulmonary embolisms within the state. The workgroup shall:

(i) Identify the aggregate number of people who experience blood clots and pulmonary embolisms each year in this state.

(ii) Identify how data is collected regarding blood clots, pulmonary embolisms, and adverse health outcomes associated with these conditions.

(iii) Identify how blood clots and pulmonary embolisms impact the lives of people in this state.

(iv) Identify the standards of care for blood clot surveillance, detection, and treatment.

(v) Identify emerging treatments, therapies, and research relating to blood clots.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD13187-03-4

(vi) Develop a risk surveillance system to help health care providers identify patients who may be at a higher risk of forming blood clots and pulmonary embolisms.

(vii) Develop policy recommendations to help improve patient awareness of blood clot risks.

(viii) Develop policy recommendations to help improve surveillance and detection of patients who may be at a higher risk of forming blood clots in licensed health care facilities, including hospitals, nursing homes, assisted living facilities, residential treatment facilities, and ambulatory surgical centers.

(ix) Develop policy recommendations relating to guidelines used that affect the standard of care for patients at risk of forming blood clots.

(x) Develop policy recommendations relating to providing patients and their families with written notice of increased risks of forming blood clots.

(d) The chair is authorized to create subcommittees to help with research, scheduling speakers on important subjects, and drafting a workgroup report and policy recommendations.

(e) No later than one year after the effective date of this subdivision, the workgroup shall submit their recommendations in the form of a written report to the commissioner, the speaker of the assembly, the temporary president of the senate, the minority leader of the assembly and the minority leader of the senate.

(f) Upon receipt of the workgroup's report, the commissioner shall publish such recommendations on the department's website.

§ 2. This act shall take effect on the ninetieth day after it shall have become a law and shall expire and be deemed repealed two years and ninety days after it shall have become a law.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.